Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 May;26(5):705-11.
doi: 10.1007/s00467-010-1714-8. Epub 2010 Dec 21.

Fetal environment, epigenetics, and pediatric renal disease

Affiliations
Review

Fetal environment, epigenetics, and pediatric renal disease

Robert Woroniecki et al. Pediatr Nephrol. 2011 May.

Abstract

The notion that some adult diseases may have their origins in utero has recently captured scientists' attention. Some of these effects persist across generations and may involve epigenetic mechanisms. Epigenetic modifications, DNA methylation together with covalent modifications of histones, alter chromatin density and accessibility of DNA to cellular machinery, modulating the transcriptional potential of the underlying DNA sequence. Here, we will discuss the different epigenetic modifications and their potential role in and contribution to renal disease development.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The phenotype (or disease) development depends on genetic and epigenetic factors. During normal development, somatic cells descending from a single progenitor and containing a similar genotype will differentiate to acquire diverse biological functions by expressing and repressing different sets of genes via establishing new epigenetic marks. While the genotype of an individual does not change, hyperglycemia, uremia, different dietary and environmental factors might change the epigenome of cells leading to differences in gene and protein expression. Differences in the epigenotype might be responsible for the development of a differing (including disease) phenotype. While the genotype is stable, there is a more dynamic link between environmental factors and phenotype development
Fig. 2
Fig. 2
The effect of different external signals depends on epigenetic modification in the target cells. The cellular response to external signals may reflect chromatin-based (epigenetic) differences superimposed on the static genetic code. In this example, the 5-regulatory region of a disease susceptibility gene is depicted in cells. In some cells, the promoter assumes an “open” chromatin architecture characterized by activated histone posttranslational marks, decreased nucleosome density, and the lack of DNA methylation. RNA polymerase II is recruited to the promoter, resulting in productive transcription. Alternatively, in other cells the genetically identical promoter assumes a “closed” chromatin configuration characterized by repressive posttranslational marks, increased nucleosome density, and prominent DNA methylation. RNA polymerase II is not recruited to the promoter, and no transcription occurs. Transcriptionally competent euchromatin is usually associated with unmethylated DNA, and trimethyl H3K4me3 and H3K36me3 marks. Transcription-ally incompetent heterochromatin is generally associated with methylated DNA and trimethyl H3K27 marks
Fig. 3
Fig. 3
Different histone tail modifications and their effects on gene transcription. a The different H3 histone tail modifications at the amino acid resolution level (aa 1-79) and their modifications, ac acetylation, me methylation, ph phosphorylation. Below is the most common histone modification and the effect on gene transcription i.e. repression and/or active transcription. b The different post-translational modifications of the different histone amino-acids

References

    1. Wood AJ, Oakey RJ. Genomic imprinting in mammals: emerging themes and established theories. PLoS Genet. 2006;2:e147. - PMC - PubMed
    1. Knoll JH, Nicholls RD, Magenis RE, Graham JM, Jr, Lalande M, Latt SA. Angelman and Prader-Willi syndromes share a common chromosome 15 deletion but differ in parental origin of the deletion. Am J Med Genet. 1989;32:285–290. - PubMed
    1. Knoll JH, Nicholls RD, Magenis RE, Glatt K, Graham JM, Jr, Kaplan L, Lalande M. Angelman syndrome: three molecular classes identified with chromosome 15q11q13-specific DNA markers. Am J Hum Genet. 1990;47:149–154. - PMC - PubMed
    1. Hong H, Takahashi K, Ichisaka T, Aoi T, Kanagawa O, Nakagawa M, Okita K, Yamanaka S. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature. 2009;460:1132–1135. - PMC - PubMed
    1. Yamanaka S. Elite and stochastic models for induced pluripotent stem cell generation. Nature. 2009;460:49–52. - PubMed

Publication types